Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease

Patients with chronic inflammatory diseases (CID) experience accelerated loss of bone mineral density, which is often accompanied by increased vascular calcification. These disturbances can be attenuated by therapies for inflammation, such as the tumor necrosis factor inhibitor infliximab. Calciprot...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiong, Mark K, Smith, Edward R, Toussaint, Nigel D, Al‐Khayyat, Hasan F, Holt, Stephen G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216135/
https://www.ncbi.nlm.nih.gov/pubmed/34189386
http://dx.doi.org/10.1002/jbm4.10497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216135/
https://www.ncbi.nlm.nih.gov/pubmed/34189386
http://dx.doi.org/10.1002/jbm4.10497

Ejemplares similares